Nogo pathway-associated gene-silencing siRNAs (Alnylam/Merck)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNogo pathway-associated gene-silencing siRNAs (Alnylam/Merck)
Drug Alias NameNogo pathway-associated gene-silencing siRNAs (Alnylam)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionReticulon-4 modulators
TargetsReticulon-4
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncAlnylam Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A